Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2012 2
2013 1
2014 1
2015 2
2016 1
2017 1
2018 3
2019 3
2020 1
2021 4
2022 2
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants.
García-Pérez J, Borobia AM, Pérez-Olmeda M, Portolés A, Castaño L, Campins-Artí M, Bertrán MJ, Bermejo M, Arribas JR, López A, Ascaso-Del-Rio A, Arana-Arri E, Fuentes Camps I, Vilella A, Cascajero A, García-Morales MT, Castillo de la Osa M, Pérez Ingidua C, Lora D, Jiménez-Santana P, Pino-Rosa S, Gómez de la Cámara A, De La Torre-Tarazona E, Calonge E, Cruces R, Belda-Iniesta C, Alcamí J, Frías J, Carcas AJ, Díez-Fuertes F; CombiVacS Study Group. García-Pérez J, et al. iScience. 2024 Aug 14;27(9):110728. doi: 10.1016/j.isci.2024.110728. eCollection 2024 Sep 20. iScience. 2024. PMID: 39286494 Free PMC article.
Usefulness of Xpert MTB/RIF and Xpert Ultra to Categorize Risk of Tuberculosis Transmission to Household Contacts.
Mol A, Sánchez-Montalvá A, Espinosa-Pereiro J, Aznar ML, Salvador F, Bosch-Nicolau P, de Souza-Galvão ML, Jiménez MÁ, Rodrigo-Pendás JÁ, Millet JP, Saborit N, Broto C, Molina I, Tórtola T. Mol A, et al. Among authors: rodrigo pendas ja. Open Forum Infect Dis. 2024 Aug 6;11(8):ofae450. doi: 10.1093/ofid/ofae450. eCollection 2024 Aug. Open Forum Infect Dis. 2024. PMID: 39165580 Free PMC article.
Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab.
Carvajal R, Zabalza A, Carbonell-Mirabent P, Martínez-Gómez X, Esperalba J, Pappolla A, Rando A, Cobo-Calvo A, Tur C, Rodriguez M, Río J, Comabella M, Castilló J, Rodrigo-Pendás JÁ, Braga N, Mongay-Ochoa N, Guío-Sánchez C, Vidal-Jordana Á, Arrambide G, Rodríguez-Acevedo B, Midaglia L, Borras-Bermejo B, Galán I, Sastre-Garriga J, Montalban X, Otero-Romero S, Tintoré M. Carvajal R, et al. Among authors: rodrigo pendas ja. JAMA Netw Open. 2024 Apr 1;7(4):e246345. doi: 10.1001/jamanetworkopen.2024.6345. JAMA Netw Open. 2024. PMID: 38607624 Free PMC article.
Influenza Vaccine Effectiveness against Hospitalization, Season 2021/22: A Test-Negative Design Study in Barcelona.
Fornaguera M, Parés-Badell O, Carbonés-Fargas Í, Andrés C, Rodrigo-Pendás JÁ, Borras-Bermejo B, Armadans-Gil L, Tejada G, Guananga D, Vivet-Escalé M, Peñalver-Piñol A, Torrecilla-Martínez I, Del Oso A, Martínez-Gómez X, Antón A, Otero-Romero S. Fornaguera M, et al. Among authors: rodrigo pendas ja. Vaccines (Basel). 2023 Sep 2;11(9):1450. doi: 10.3390/vaccines11091450. Vaccines (Basel). 2023. PMID: 37766127 Free PMC article.
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients.
Carvajal R, Tur C, Martínez-Gómez X, Bollo L, Esperalba J, Rodriguez M, Pappolla A, Cobo-Calvo A, Carbonell P, Borras-Bemejo B, Río J, Castilló J, Braga N, Mongay-Ochoa N, Rodrigo-Pendás JÁ, Vidal-Jordana Á, Arrambide G, Rodríguez-Acevedo B, Zabalza A, Midaglia L, Galán I, Comabella M, Sastre-Garriga J, Montalban X, Tintoré M, Otero-Romero S. Carvajal R, et al. Among authors: rodrigo pendas ja. Mult Scler. 2023 Dec;29(14):1841-1848. doi: 10.1177/13524585231200303. Epub 2023 Sep 20. Mult Scler. 2023. PMID: 37728389 Free PMC article.
Adherence and Toxicity during the Treatment of Latent Tuberculous Infection in a Referral Center in Spain.
Puyana Ortiz JD, Garcés Rodríguez AC, Aznar ML, Espinosa Pereiro J, Sánchez-Montalvá A, Martínez-Campreciós J, Saborit N, Rodrigo-Pendás JÁ, García Salgado G, Broto Cortes C, Delcor NS, Oliveira I, Treviño Maruri B, Ciruelo DP, Salvador F, Bosch-Nicolau P, Torrecilla-Martínez I, Zules-Oña R, Tórtola Fernández MT, Molina I. Puyana Ortiz JD, et al. Among authors: rodrigo pendas ja. Trop Med Infect Dis. 2023 Jul 19;8(7):373. doi: 10.3390/tropicalmed8070373. Trop Med Infect Dis. 2023. PMID: 37505669 Free PMC article.
Increased RSV-A Bronchiolitis Severity in RSV-Infected Children Admitted to a Reference Center in Catalonia (Spain) Between 2014 and 2018.
Vila J, Lera E, Peremiquel-Trillas P, Andrés C, Martínez L, Barceló I, Carsi A, Balcells J, Ángel Rodrigo-Pendás J, Soler-Palacín P, Rodrigo C, Antón A. Vila J, et al. Among authors: angel rodrigo pendas j. J Pediatric Infect Dis Soc. 2023 Apr 18;12(3):180-183. doi: 10.1093/jpids/piad009. J Pediatric Infect Dis Soc. 2023. PMID: 36744919
Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination.
Parés-Badell O, Zules-Oña R, Armadans L, Pinós L, Borrás-Bermejo B, Otero S, Rodrigo-Pendás JÁ, Vivet-Escalé M, Cossio-Gil Y, Agustí A, Aguilera C, Campins M, Martínez-Gómez X. Parés-Badell O, et al. Among authors: rodrigo pendas ja. Vaccines (Basel). 2022 Jul 29;10(8):1217. doi: 10.3390/vaccines10081217. Vaccines (Basel). 2022. PMID: 36016105 Free PMC article.
Local and Systemic Adverse Reactions to mRNA COVID-19 Vaccines Comparing Two Vaccine Types and Occurrence of Previous COVID-19 Infection.
Parés-Badell O, Martínez-Gómez X, Pinós L, Borras-Bermejo B, Uriona S, Otero-Romero S, Rodrigo-Pendás JÁ, Cossio-Gil Y, Agustí A, Aguilera C, Campins M. Parés-Badell O, et al. Among authors: rodrigo pendas ja. Vaccines (Basel). 2021 Dec 10;9(12):1463. doi: 10.3390/vaccines9121463. Vaccines (Basel). 2021. PMID: 34960209 Free PMC article.
25 results